User talk:ProbablyAndrewKuznetsov

Welcome!

Hello, Wikipedian Andrew Kuznetsov! Welcome to Wikipedia! Thank you for your contributions. You may benefit from following some of the links below, which will help you get the most out of Wikipedia. If you have any questions you can ask me on my talk page, or place {{helpme}} on your talk page and ask your question there. Please remember to sign your name on talk pages by clicking or by typing four tildes "~~~~"; this will automatically produce your name and the date. If you are already excited about Wikipedia, you might want to consider being "adopted" by a more experienced editor or joining a WikiProject to collaborate with others in creating and improving articles of your interest. Click here for a directory of all the WikiProjects. Finally, please do your best to always fill in the edit summary field when making edits to pages. Happy editing! Drm310 🍁 (talk) 21:39, 24 February 2020 (UTC) Getting Started Contributing to Wikipedia • Tutorial • Your first article The five pillars of Wikipedia • Simplified ruleset How to: edit a page • upload an image Getting Help Frequently Asked Questions Directories and indexes Where to: ask questions • make requests Tip of the day Request administrator attention Policies and Guidelines Neutral point of view • Reliable sources Verifiability • Citing sources • No original research What Wikipedia is not • Biographies of living persons Manual of Style (Simplified) • Three-revert rule Copyrights • Non-free content • Image use policy External links • Spam • Vandalism • Sock puppetry Deletion policy • Conflict of interest • Notability The Community Community Portal • Adopt-a-user program Assume good faith • Civility • Etiquette No personal attacks • Resolving disputes Build consensus • Village pump IRC channels • Mailing lists The Signpost (Wikipedia's newspaper) Things to do Be bold in editing • Help develop an article Maintenance • Peer review • Requested articles Join a WikiProject • Translating articles Cleaning up: General • Spam • Vandalism Miscellaneous Categories • Disambiguity • Stubs User pages • Talk pages Useful templates • Tools • User scripts

February 2020

Hello, I'm Mr Xaero. I wanted to let you know that one or more of your recent contributions to User talk:Tgeorgescu have been undone because they appeared to be promotional. Advertising and using Wikipedia as a "soapbox" are against Wikipedia policy and not permitted; Wikipedia articles should be written objectively, using independent sources, and from a neutral perspective. Take a look at the welcome page to learn more about Wikipedia. Thank you. Mr Xaero ^☎️ 00:18, 26 February 2020 (UTC)

FAQs

There is always a possibility that you are a genuine researcher who is "part of a research team at Carnegie Mellon University ... building tools to help create FAQs for the millions of Wikipedia pages that don't have them". Accordingly, let me suggest that you spend a bit of time getting accustomed to editing Wikipedia. After that, you could ask about FAQ pages at WP:Teahouse or possibly WP:MISC. In short, FAQs will not be added to thousands let alone millions of unFAQed pages. Johnuniq (talk) 02:39, 26 February 2020 (UTC)

Thank you for the direction, Johnuniq. --ProbablyAndrewKuznetsov (talk) 05:29, 26 February 2020 (UTC)

They are indeed added on a case-by-case basis when needed (i.e. persistent questions or misconceptions posted on the talk page again and again). —PaleoNeonate – 05:03, 26 February 2020 (UTC)

We'd like to get in touch with editors that have gone through the process of identifying these questions case-by-case and created FAQ sections that address them. --ProbablyAndrewKuznetsov (talk) 05:29, 26 February 2020 (UTC)

Your thread has been archived

Hi ProbablyAndrewKuznetsov! You created a thread called Questions to any editors who've written a FAQ section in a talk page before at Wikipedia:Teahouse, but it has been archived because there was no discussion for a few days. You can still find the archived discussion here. If you have any additional questions that weren't answered then, please create a new thread. Archival by Lowercase sigmabot III, notification delivery by Muninnbot, both automated accounts. You can opt out of future notifications by placing {{bots|deny=Muninnbot}} (ban this bot) or {{nobots}} (ban all bots) on your user talk page. Muninnbot (talk) 19:00, 29 February 2020 (UTC)

Nitazoxanide

Hello, thank you for your edits. I noticed that you added nitazoxanide to the table in this article COVID-19 drug repurposing research. I checked the source and my interpretation was that the source found it to be effective in vitro at inhibiting SARS-CoV-2 at a low concentration (the authors went on to recommend further in vivo testing), but yet you added an x to indicate that no significant antiviral properties were found. Either I am misinterpreting the source or you are? What is your interpretation of the source?--Literaturegeek | T@1k? 12:13, 22 March 2020 (UTC)

Looked it over, you're right. Thanks for taking a look over and changing. Maybe at some point we should add that its 'Selectivity Index' (SI) set it apart from the other two drugs in the study. ProbablyAndrewKuznetsov (talk) 22:50, 22 March 2020 (UTC)

No worries, yes I noticed the selectivity index not being as favourable as remdesivir and chloroquine. I am no expert but my understanding is that nitazoxanide is considered to be quite a safe drug with a benign side effect profile so I am somewhat surprised that it’s selectivity index was worse than chloroquine but I am not an expert in selectivity indexes. But we could perhaps mention the selectivity index or else just leave it until better research comes out. I imagine some doctors will start studies of nitazoxanide in COVID-19 patients soon, maybe in India and South America where the drug is widely prescribed.--Literaturegeek | T@1k? 23:03, 22 March 2020 (UTC)